Impact of Diabetes Mellitus on Early and Midterm Outcomes After Transcatheter Aortic Valve Implantation (from a Multicenter Registry)
- 1 February 2014
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 113 (3) , 529-534
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experienceInternational Journal of Cardiology, 2013
- The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesisEuroIntervention, 2012
- Use and Misuse of Multivariable Approaches in Interventional Cardiology Studies on Drug‐Eluting Stents: A Systematic ReviewJournal of Interventional Cardiology, 2012
- Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve ReplacementNew England Journal of Medicine, 2012
- Usefulness of Periprocedural Bleeding to Predict Outcome After Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2012
- One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) RegistryCirculation, 2011
- Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery diseaseJournal of Cardiovascular Medicine, 2011
- Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routesAmerican Heart Journal, 2011
- Comparison of Mortality Rates in Women Versus Men Presenting With ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2011
- Metabolic Syndrome Is Associated With More Pronounced Impairment of Left Ventricle Geometry and Function in Patients With Calcific Aortic StenosisJACC, 2010